Karthik Radhakrishnan - 01 Jul 2024 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Reporting relationship: Chief Financial Officer
Issuer ticker: MNPR
Reported as of: 01 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jul 2024, 18:22:35 UTC
Next SEC filing: 30 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Karthik Radhakrishnan

Key filing fact

Karthik Radhakrishnan filed Form 4 for Monopar Therapeutics (MNPR) on 03 Jul 2024.

Key facts

This page summarizes Karthik Radhakrishnan's Form 4 filing for Monopar Therapeutics (MNPR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jul 2024, 18:22.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MNPR transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +125,000
Change %
Price: $0.000000
Shares after: 125,000
Date: 01 Jul 2024
Ownership: Direct
Underlying class: Commom Stock
Underlying amount: 125,000
Exercise price: $0.7414
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On July 1, 2024, the reporting person was granted 125,000 stock options, vesting 6/48ths (15,625 shares) on December 31, 2024, and 1/48th every month thereafter until the stock option is fully vested on July 1, 2028.